Jeffrey W. Jacobs - 08 Nov 2021 Form 4 Insider Report for ARDELYX, INC. (ARDX)

Role
Chief Scientific Officer
Signature
/s/ Elizabeth Grammer, Attorney-in-Fact for Jeffrey W. Jacobs
Issuer symbol
ARDX
Transactions as of
08 Nov 2021
Net transactions value
-$2,556
Form type
4
Filing time
10 Nov 2021, 16:17:02 UTC
Previous filing
24 Aug 2021
Next filing
16 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARDX Common Stock Sale $2,556 -2,166 -1.6% $1.18 130,237 08 Nov 2021 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 29, 2021.
F2 Reflects the adjusted total which includes the purchase of 2,166 shares under the Ardelyx Employee Stock Purchase Plan on February 28, 2021.
F3 Reflects the adjusted total which includes the purchase of 2,540 shares under the Ardelyx Employee Stock Purchase Plan on August 31, 2021.